4.53 USD
+0.1 (+2.26%)
ChartMill assigns a Buy % Consensus number of 82% to OBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.6. This target is 200.22% above the current price.
OBIO was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about OBIO.
In the previous month the buy percentage consensus was at a similar level.
OBIO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | BTIG | Downgrade | Buy -> Neutral |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-20 | BTIG | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Barclays | Initiate | Overweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-25 | B. Riley Securities | Initiate | Buy |
| 2024-06-12 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-19 | Jefferies | Initiate | Buy |
| 2023-08-11 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-09 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-02-24 | Piper Sandler | Initiate | Overweight |
| 2023-02-07 | Chardan Capital | Initiate | Buy |
ORCHESTRA BIOMED HOLDINGS IN / OBIO FAQ
Can you provide the average price target for ORCHESTRA BIOMED HOLDINGS IN stock?
13 analysts have analysed OBIO and the average price target is 13.6 USD. This implies a price increase of 200.22% is expected in the next year compared to the current price of 4.53.
What is the consensus rating for ORCHESTRA BIOMED HOLDINGS IN (OBIO) stock?
The consensus rating for ORCHESTRA BIOMED HOLDINGS IN (OBIO) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for OBIO stock?
The number of analysts covering ORCHESTRA BIOMED HOLDINGS IN (OBIO) is 13.